{"disease":{"id":"multiple-system-atrophy-parkinson-variant-disorder","name":"multiple system atrophy parkinson variant disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04608604","title":"Mobility in Atypical Parkinsonism: a Trial of Physiotherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Victoria Sidoroff","has_results":false},{"nct_id":"NCT04617873","title":"DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"zhangyuqing","has_results":false},{"nct_id":"NCT04616456","title":"Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}